John Duffey Email & Phone Number

Chicago, Il, Us

Mettawa, Illinois

Led combined sales and marketing organization of more than 1,400 employees (including 8 sales forces) across 20 therapeutic areas, including infectious disease, gastroenterology, endocrinology, metabolic, urology, gynecology, and other areas, with specialty franchise generating over $6B in annual net sales with combined portfolio of 85 brands and 20 AG's treating over 8M patients.-Defined Specialty long-range strategic plan - developed and supported staff of 6 VP/GM’s in leading their franchises to achieve Specialty and AbbVie long-range strategic objectives.-Led integration of acquired Allergen Specialty businesses that included 40 products and 800 new employees across gastroenterology, primary care, women's heath, and anti-infective - consistently exceeded sales targets of deal model forecast. -Oversaw pricing, access, and distribution strategies across entire portfolio of Specialty products, including customized patient support programs and co-pay offerings.-Directed therapeutic area strategy council comprised of commercial, R&D, medical, regulatory and clinical in advancing ongoing asset development and defining specialty portfolio expansion and business development strategies. -Specialty commercial lead for in-licensing, co-development and co-promotion agreements with industry partners. -Sustained a culture of excellence within marketing teams and across 8 sales forces consistently exceeding sales performance targets and cultural metrics – employee culture survey scores among the highest across AbbVie.

Mettawa, Illinois

Led HCV business, including VIEKIRA. Directed franchise sales, marketing and cross-functional support ways of working and culture turnaround elevating culture scores and launch preparedness in advance of MAVYRET launch. -Launched MAVYRET Aug. 2017, achieved blockbuster status in first year of launch and was recognized by Fierce Pharma in 2020 as top drug launch based on sales for first four full quarters on market. -Recognized for team success with numerous President’s Awards and Chairman’s Award from CEO.-Defined MAVYRET pricing and access strategy at launch and ongoing contracting plan to maintain parity access and reduce payor barriers limiting treatment of HCV patients, with MAVYRET pricing and contracting strategy also recognized with President’s Award.-Guided integrated brand team HCV and MAVYRET lifecycle strategy including data generation, label enhancements, and new indications.

Mettewa, Illinois

Directed growth of HUMIRA Dermatology franchise to over $2B, which included successfully commercializing HUMIRA for Ps and PSA and launching the Hidradenitis Suppurativa (HS) indication. -Led Derm Integrated Brand (IBT) including sales and marketing to achieve all franchise key performance targets, including HUMIRA patients treated, TRx volume, and First-Line share.-Guided successful franchise culture turnaround, significantly improving scores across all ten culture dimensions and improving Derm Integrated Brand Team survey results.-Headed Dermatology integrated brand team recognized with numerous awards, including 2014 Award USA for Derm Promotion Transformation, 2015 President’s Award and Best in Class finalist for HUMIRA Messaging and Competitive Response Planning, and 2016 President’s Award for HS Launch and HS Disease Awareness Campaign. -Orchestrated organizational cross-functional assessment that informed enterprise decision to in-license Risankizumab (Skyrizi) in Dermatology space.

Mettewa, Il

Led cardiovascular sales organization (over 2,000 employees) managing a portfolio of brands (TriCor, TRILIPIX, Niaspan, Simcor) contributing over $2.5B in net sales annually. -Managed franchise SG&A in defining brand promotional and investment strategies to maximize margin. -Guided franchise lifecycle strategies, which included downsizing sales organization based on franchise LOE dates, managing reductions in sales force of over 750 representatives / 95 managers (Jan. 2012), and redeployment of over 300 representatives to other businesses. -Developed new sales force go-to-market model and end-of-lifecycle franchise exit strategy adopted across the broader organization.

Lake Forest, Illinois, United States

Developed and executed fibrate franchise key commercial strategies (TRILIPIX / TriCor), valued at over $1.5B in net sales. -Led successful execution of TRILIPIX commercial launch, noted by IMS as most successful primary care product launch in four years and fourth-most successful Abbott launch (behind HUMIRA indications).-Managed cross-functional collaboration with access, trade, pricing, and contracting in executing franchise pricing and retail distribution plan. -Orchestrated lipid enterprise cross-functional portfolio expansion and pipeline commercial development strategies including alliance management with co-development partners.

Lake Forest, Illinois, United States

Led all commercial activities in support of on-market products such as Synthroid, Cardizem LA, Tarka, Teveten, and Meridia, as well as overseeing commercial development for inhaled insulin and Flutiform. -Led commercial assessment of KOS inhaled insulin product, resulting in reprioritizing of resources to other Abbott R&D projects. -Led franchise margin maximization strategy successfully and exceeded franchise sales and margin targets by 6% and 17% respectively, achieving net sales of $744M.

Lake Forest, Illinois, United States

Implemented and developed Biaxin XL strategic commercial plan including cross-functional leadership of brand life-cycle strategy. -Managed cross-functional collaboration with managed care, pricing, and contracting in execution of Biaxin XL payor coverage and margin optimization pricing plan. -Collaborated with legal, commercial, and regulatory / medical in execution of product lifecycle strategy. -Named recipient of President’s Award for development and execution of Biaxin XL, life-cycle strategy and Teva response plan.

Lake Forest, Illinois, United States

Developed and implemented Zemplar Capsule commercial marketing strategy, including pre-launch medical education and commercial launch plan. -Managed cross-functional relationship with clinical development, medical affairs, and regulatory to execute product labeling, R&D, and publication strategy. -Served as marketing lead on cross-functional managed care and pricing team. -Led PTH testing strategy and partnership with leading reference labs (Quest and LabCorp). -Served as Zemplar Capsule team lead on strategic alliance / partnership with Quintiles.

Boston, Massachusetts, United States

Led comprehensive commercial launch plan for FirstCyte Breast Test-Breast ductal lavage procedure for diagnosis and risk assessment of breast cancer and strategic commercial plan for ThinPrep Pap Test-Cervical Cancer Screening Test. Led cross-functional team with clinical development, medical affairs, and regulatory to facilitate long-term clinical development and publication strategies.

Lake Forest, Illinois, United States

Led franchise commercial teams including marketing, access and sales force in executing franchise commercial strategies to optimize growth and profitability of Zemplar and Calcijex. Facilitated product lifecycle strategies, defined business long-term growth plan and led business development activities to assess new product and business expansion opportunities.

Deerfield, Illinois, United States

Defined strategic marketing and sales force promotional plan to maximize growth and profitability of Prevacid. Managed $130M promotional budget, including Prevacid direct-to-consumer advertising, professional promotion, and sales force promotion. Led Prevacid, PrevPac, and Biaxin co-promotion with Abbott.

Deerfield, Illinois, United States

Developed strategic plan for urology and gynecology integrated health markets and payor strategies including third-party insurance, Medicaid, Medicare, and Medicare risk plans. Developed promotional plan and payor team training curriculums for payors and integrated health systems.

Chicago, Illinois, United States

Managed ten sales representatives in promoting Prevacid and Biaxin. Directed negotiations for Prevacid formulary access in community hospitals and local managed care organizations. Named recipient of Winners Circle Award for exceeding 100% of quarterly sales goal for 12 consecutive quarters.

Deerfield, Illinois, United States

Built strategic and tactical marketing plan for Lupron gynecology indications. Developed promotional plan and gynecology medical education plan, including CME programs, regional symposia, and local speaker programs. Managed Metro-Gel Vaginal co-promotion with Curatek Pharmaceuticals.

Boston, Massachusetts, United States

Performed commercial analysis, development, and implementation of customized Lupron brand marketing plans in collaboration with local sales management for Northeast region. Nominated for National Marketer of Year award in 1994. Awarded Excalibur Guild (All-Star) award for finishing in top 10% of sales for field marketing team. Achieved over 100% quarterly quota attainment for six consecutive quarters.

Portland, Maine Metropolitan Area

Managed Northeast sales territory, calling on urologists, oncologists, and gynecologists. Promoted products including Lupron Depot 3.75 for endometriosis and uterine fibroids, Lupron Depot 7.5mg for prostate cancer, Hytrin for benign prostatic hyperplasia, and Ogen for hormone replacement. Named recipient of President’s Award for Competitive Selling Training Program.

Bachelor Of Science - Bs, Marketing/Marketing Management, General

Education record